HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshiharu Okamoto Selected Research

Chitin

1/2017Oral Administration of Surface-Deacetylated Chitin Nanofibers and Chitosan Inhibit 5-Fluorouracil-Induced Intestinal Mucositis in Mice.
9/2016Biomaterials based on freeze dried surface-deacetylated chitin nanofibers reinforced with sulfobutyl ether β-cyclodextrin gel in wound dressing applications.
1/2016Chitin nanofibrils suppress skin inflammation in atopic dermatitis-like skin lesions in NC/Nga mice.
12/2015Protective Effect of Chitin Urocanate Nanofibers against Ultraviolet Radiation.
7/2015Effects of Surface-Deacetylated Chitin Nanofibers in an Experimental Model of Hypercholesterolemia.
6/2015Favorable effects of superficially deacetylated chitin nanofibrils on the wound healing process.
1/2015Anticancer and anti-inflammatory properties of chitin and chitosan oligosaccharides.
10/2014Preparation and biomedical applications of chitin and chitosan nanofibers.
9/2012α-Chitin nanofibrils improve inflammatory and fibrosis responses in inflammatory bowel disease mice model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshiharu Okamoto Research Topics

Disease

42Neoplasms (Cancer)
09/2022 - 07/2008
6Inflammation (Inflammations)
11/2017 - 09/2014
6Melanoma (Melanoma, Malignant)
01/2015 - 04/2012
4Wounds and Injuries (Trauma)
05/2018 - 10/2014
4Hyperthermia
06/2014 - 04/2012
3Carcinoma (Carcinomatosis)
03/2021 - 04/2019
3Osteoarthritis
05/2018 - 05/2013
3Sarcoma (Soft Tissue Sarcoma)
06/2017 - 01/2014
3Breast Neoplasms (Breast Cancer)
04/2017 - 09/2016
2Necrosis
03/2021 - 01/2014
2Burns
10/2020 - 01/2014
2Hemorrhage
10/2020 - 06/2020
2Brain Neoplasms (Brain Tumor)
02/2017 - 12/2015
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2015 - 09/2012
2Neoplasm Metastasis (Metastasis)
01/2015 - 12/2012
2Obesity
10/2014 - 02/2014
1Otitis Media
04/2022
1Blister (Bulla)
04/2022
1Abdominal Hernia (Abdominal Hernias)
04/2022
1Adenocarcinoma of Lung
08/2021
1Mastitis
01/2021
1Lymphoma (Lymphomas)
10/2020
1Thrombosis (Thrombus)
06/2020
1Snake Bites (Snake Bite)
06/2020
1Corneal Diseases (Corneal Disease)
05/2020
1Meningioma (Meningiomas)
01/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020
1Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2019
1Alopecia (Baldness)
04/2019
1Glioma (Gliomas)
01/2019
1Glioblastoma (Glioblastoma Multiforme)
01/2019
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2019
1Prostatic Neoplasms (Prostate Cancer)
01/2019
1Osteosarcoma (Osteogenic Sarcoma)
01/2019
1Chondrosarcoma
01/2019
1Liver Neoplasms (Liver Cancer)
01/2019

Drug/Important Bio-Agent (IBA)

111-phenyl-3,3-dimethyltriazene (PDT)IBA
09/2022 - 04/2012
9ChitinIBA
01/2017 - 09/2012
8Indocyanine Green (Cardio-Green)FDA LinkGeneric
10/2020 - 04/2012
7Glucosamine (Dona)IBA
05/2018 - 08/2012
6AcidsIBA
08/2021 - 12/2015
5Amino AcidsFDA Link
08/2022 - 12/2012
5Glucose (Dextrose)FDA LinkGeneric
03/2021 - 08/2012
5ChitosanIBA
04/2019 - 06/2010
4Pharmaceutical PreparationsIBA
01/2019 - 10/2014
4lupeolIBA
01/2015 - 07/2013
3Messenger RNA (mRNA)IBA
04/2019 - 01/2016
3Oxidoreductases (Dehydrogenase)IBA
04/2017 - 02/2015
3Biomarkers (Surrogate Marker)IBA
02/2017 - 12/2012
3CytokinesIBA
02/2015 - 06/2010
3AcetylglucosamineIBA
01/2015 - 08/2012
3TriterpenesIBA
01/2015 - 07/2013
2Photosensitizing Agents (Photosensitizers)IBA
09/2022 - 05/2019
2liposomal doxorubicin (Doxil)FDA Link
12/2021 - 08/2020
2Oxygen (Dioxygen)IBA
03/2021 - 02/2021
2Reactive Oxygen Species (Oxygen Radicals)IBA
03/2021 - 10/2019
2Talaporfin (talaporfin sodium)IBA
02/2021 - 06/2017
2protoporphyrin IXIBA
01/2020 - 04/2019
2Phospholipids (Phosphatides)FDA LinkGeneric
01/2019 - 12/2015
2Bleomycin (Blenoxane)FDA LinkGeneric
01/2018 - 04/2016
2Biological ProductsIBA
09/2016 - 01/2015
2CollagenIBA
06/2015 - 05/2013
2OligosaccharidesIBA
01/2015 - 01/2015
1RNA (Ribonucleic Acid)IBA
09/2022
1Indicators and Reagents (Reagents)IBA
08/2022
1Essential Amino AcidsIBA
08/2022
1Amino Acid Transport Systems (Amino Acid Transporter)IBA
08/2022
11-dodecylpyridoxal (PLD)IBA
12/2021
1chlorinIBA
02/2021
1Immune Checkpoint InhibitorsIBA
02/2021
1Mannose (D-Mannose)IBA
02/2021
1SugarsIBA
02/2021
1beta-lactamase CTX-2IBA
01/2021
1LipidsIBA
08/2020
1FibrinIBA
06/2020
1Tyrosine Kinase InhibitorsIBA
01/2020
1Proteins (Proteins, Gene)FDA Link
01/2020
1Monensin (Coban)IBA
01/2020
1Antimalarials (Antimalarial Agents)IBA
10/2019
1artemisinin (artemisinine)IBA
10/2019
1phytochlorinIBA
05/2019
1Ferrochelatase (Heme Synthetase)IBA
04/2019
1EnzymesIBA
04/2019
1Therapeutic UsesIBA
04/2019
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2019
1Singlet OxygenIBA
01/2019
1MicellesIBA
01/2019

Therapy/Procedure

19Therapeutics
09/2022 - 04/2012
8Photochemotherapy (Photodynamic Therapy)
08/2021 - 04/2012
6Drug Therapy (Chemotherapy)
04/2019 - 01/2014
6Oral Administration
01/2017 - 08/2012
3Radiotherapy
10/2020 - 09/2018
2Sutures (Suture)
04/2022 - 01/2014
2Lasers (Laser)
05/2019 - 06/2017
2Injections
06/2014 - 07/2013
1Osteotomy
04/2022
1Precision Medicine
08/2020
1Glossectomy
06/2020
1Contact Lenses
05/2020
1Aftercare (After-Treatment)
09/2018